A new era of cancer treatment
This is predicted by world-renowned researcher, Professor Richard Marais, as he receives the Worldwide Cancer Research Colin Thomson Memorial Medal for his outstanding contribution to cancer research.
The Beatson International Cancer conference takes place in Glasgow this week from 3rd-6th July. Worldwide Cancer Research is proud to co-sponsor this important meeting of minds and continue encouraging scientific collaborations around the world.
The Colin Thomson Memorial Medal has been awarded each year since 2007 to a scientist in recognition of their outstanding contribution to research into cancer. It is named after Dr Colin Thomson, a lecturer in theoretical chemistry who established Worldwide Cancer Research in 1984.
This year’s medal winner and keynote speaker is a former Worldwide Cancer Research grant holder, Professor Richard Marais PhD. He is Director of the Cancer Research UK Manchester Institute and a Professor of Molecular Oncology at the University of Manchester.
This week it also emerged that Professor Marais and colleagues in Manchester will form a key element of US President Barack Obama's "moonshot" initiative to revolutionise cancer diagnosis and treatment.
This ties in with the focus of Professor Marais’s talk at the Beatson International Cancer Conference – “a new era of cancer treatment”. In his keynote address, Professor Marais will discuss how new therapies, including immunotherapy, where a patient’s own immune system is bolstered to attack tumour cells, is revolutionizing cancer treatment. However, these new therapies do not work for all patients, and for other people the cancer can often overcome the therapies, leaving patients with few options. The future of cancer medicine holds great promise, but there are substantial challenges.